DE:PF0 Stock Latest News
Company AnnouncementsNetraMark Founder to Highlight AI Edge in Clinical Trials at H.C. Wainwright Conference3w ago
Company AnnouncementsNetraMark Taps Veteran Finance Executive Kevin Felix as Strategic Advisor1M ago
Company AnnouncementsNetraMark Adds Veteran Pharma Executive Keith Fournier to Board to Bolster AI-Driven Clinical Strategy2M ago
Company AnnouncementsNetraMark to Highlight AI-Powered Clinical Trial Platform at Global Investment Conference2M ago
Company AnnouncementsNetraMark Books Record Contracts as NetraAI Gains Traction in Clinical Trials2M ago
Company AnnouncementsNetraMark Touts New Psychedelic Brain Research to Bolster AI-Driven Trial Design6M agoCompany AnnouncementsNetraMark Taps Landmark ROME Trial in New Precision-Oncology AI Collaboration7M ago
Company AnnouncementsNetraMark AI Uncovers Hidden Solanezumab Responders in Landmark Alzheimer’s Trial7M ago
Company AnnouncementsNetraMark Raises $3.5 Million to Advance AI-Driven Clinical Trial Analytics8M ago
Company AnnouncementsNetraMark to Uplist Shares to Toronto Stock Exchange8M ago
Company AnnouncementsNetraMark Adds Capital Markets Veteran Lawrence Guy to Board as It Scales AI Pharma Platform9M ago- Company AnnouncementsNetraMark Raises $3.11 Million in First Tranche of Private Placement9M ago
Company AnnouncementsNetraMark Launches $3.5 Million Private Placement to Advance AI Platform9M agoCompany AnnouncementsNetraMark Secures Key Commercial, Regulatory and Scientific Wins as Backlog Grows to C$2.5 Million10M ago
Company AnnouncementsNetraMark Achieves Key FDA Milestone with NetraAI Platform10M ago
Company AnnouncementsNetraMark Expands Role in Phase 3 Clinical Trials with New Contract10M ago
Company AnnouncementsNetraMark’s AI Platform Gains Recognition in npj Digital Medicine10M ago- Company AnnouncementsNetraMark Expands AI Collaboration with Major Pharmaceutical Firm11M ago
Company AnnouncementsNetraMark Expands Influence in Pharma with New AI Contract12M ago